MARCH THERAPEUTICS Trademark

Trademark Overview


On Thursday, December 8, 2022, a trademark application was filed for MARCH THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MARCH THERAPEUTICS trademark a serial number of 97710260. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 30, 2024. This trademark is owned by March Therapeutics, Inc.. The MARCH THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease

medical treatment using mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease

biotechnological research in the field of mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering
march therapeutics

General Information


Serial Number97710260
Word MarkMARCH THERAPEUTICS
Filing DateThursday, December 8, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease
Goods and Servicesmedical treatment using mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease
NOT AVAILABLE"THERAPEUTICS"
Goods and Servicesbiotechnological research in the field of mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMarch Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameMarch Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, January 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 13, 2023ASSIGNED TO EXAMINER
Friday, September 15, 2023NON-FINAL ACTION WRITTEN
Friday, September 15, 2023NON-FINAL ACTION E-MAILED
Friday, September 15, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 1, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 1, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 1, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, November 1, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, November 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2024SOU EXTENSION 1 GRANTED
Tuesday, July 30, 2024SOU EXTENSION 1 FILED
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED